|
Ekkehard Glimm
Ekkehard Glimm, PhD, is Biometrical Fellow at Novartis Pharma in
Basel, Switzerland. He joined Novartis in 2005, working first in
Oncology Biostatistics and in the Statistical Methodology group
since 2006. He is supporting clinical teams with the design and
analysis of clinical trials across all therapeutic areas in
Novartis.
Ekkehard has a background in multivariate statistics. More
recently, Ekkehard’s work has focused on dose-finding methods,
methods for multiple endpoints in clinical trials and analysis
of rare adverse events in clinical projects. Ekkehard has
authored and co-authored around 30 papers published in
peer-reviewed scientific journals.
|